Tower Research Capital LLC (TRC)

Position in KTTA — Pasithea Therapeutics Corp.

CIK 1533421 NEW YORK, NY

Position in KTTA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,375

-$2,426 QoQ

Shares Held

1,854

-37.1% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Tower Research Capital LLC (TRC) holds $67,054,823 across 440 Biotechnology names. KTTA ranks #403 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	12,112	$8,844,787
2	VRTX	Vertex Pharmaceuticals Inc / Ma	13,904	$6,208,692
3	REGN	Regeneron Pharmaceuticals, Inc.	4,378	$3,382,617
4	ALNY	Alnylam Pharmaceuticals, Inc.	9,627	$3,185,285
5	INSM	INSMED Inc	15,410	$2,519,843
6	LKFT	Lakefront Biotherapeutics NV	66,536	$1,996,080
7	MRNA	Moderna, Inc.	33,728	$1,713,382
8	BBIO	BridgeBio Pharma, Inc.	14,349	$1,065,556

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,375	1,854	-37.1%	Shares	Defined	2026-05-15
2025-12-31	$3,801	2,947	+142.2%	Shares	Defined	2026-02-17
2025-09-30	$890	1,217	-3.5%	Shares	Defined	2025-11-14
2025-06-30	$909	1,261	-61.4%	Shares	Defined	2025-08-15
2025-03-31	$4,247	3,267	+73.2%	Shares	Defined	2025-05-15
2024-12-31	$5,940	1,886	+213.8%	Shares	Defined	2025-02-13
2024-09-30	$3,257	601	-66.7%	Shares	Defined	2024-11-14
2024-06-30	$9,145	1,807	+34.3%	Shares	Defined	2024-08-13
2024-03-31	$9,751	1,345	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.